?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener
Filter & Suche
187 Ergebnisse (2 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
187 Unternehmen gefunden • Seite 3 von 8
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Lineage Cell Therapeutics Inc | 50.0 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 19.52 | 4.19 | ▲ 79.88% | ▲ 25.20% | - | - | - | -436.47% | ▲ 131.82% | -149.62% | ▲ 215.40% | -133.56% | ▲ 70.71% | 4 / 9 | −14,00 | - | 12 / 100 | −39,2 / 100 | −3,22 |
 | Liquidia Technologies Inc | 50.0 | Arzneimittel (Pharmazeutisch) | USA | 6.0 Mrd. USD | 43.10 | 98.72 | 13.25 | 30.62 | ▲ 192.49% | ▲ 2.89% | - | - | - | -43.53% | ▼ -22.33% | -32.45% | ▼ -16.23% | -25.28% | ▼ -3.90% | 5 / 9 | −5,88 | −5,5-fach | 44 / 100 | −10,1 / 100 | 6,03 |
 | Akebia Ther | 49.5 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | 6.56 | 1.20 | 10.54 | ▼ -4.37% | ▼ -56.67% | - | - | - | -2.26% | ▲ 21.31% | 9.95% | ▲ 26.45% | 28.66% | ▲ 29.39% | 6 / 9 | −13,73 | −1,6-fach | 52 / 100 | −19,5 / 100 | −2,81 |
 | Madrigal Pharmaceuticals Inc | 49.2 | Arzneimittel (Biotechnologie) | USA | 12.3 Mrd. USD | - | - | 9.62 | 23.58 | ▲ 130.27% | ▲ 50.40% | - | - | - | -30.08% | ▲ 4364.50% | -31.31% | ▲ 4241.55% | -19.83% | ▲ 3814.23% | 3 / 9 | −0,99 | −19,9-fach | 72 / 100 | −7,8 / 100 | 0,59 |
 | Phibro Animal Health Corporation | 48.5 | Arzneimittel (Pharmazeutisch) | USA | 1.4 Mrd. USD | 14.50 | 146.59 | 0.95 | 3.75 | ▲ 12.74% | ▲ 12.89% | 1.35% | - | - | 6.57% | ▲ 0.31% | 13.07% | ▲ 1.06% | 0.65% | ▲ 0.96% | 6 / 9 | 4,66 | 3-fach | 34 / 100 | 2,1 / 100 | −2,31 |
 | Harrow Health Inc | 48.3 | Arzneimittel (Pharmazeutisch) | USA | 1.3 Mrd. USD | - | 243.98 | 4.69 | 85.04 | ▲ 40.99% | ▲ 8.89% | - | - | - | -1.89% | ▲ 5.31% | 14.18% | ▲ 2.62% | 15.70% | ▲ 7.24% | 6 / 9 | 1,15 | 0-fach | 51 / 100 | −12,3 / 100 | −3,04 |
 | Novavax Inc | 48.2 | Arzneimittel (Biotechnologie) | USA | 1.6 Mrd. USD | - | - | 3.75 | -8.15 | ▲ 18.76% | - | - | - | - | 39.19% | ▲ 39.63% | 50.14% | ▲ 39.84% | -22.27% | ▼ -7.37% | 6 / 9 | −7,22 | −3,8-fach | 89 / 100 | 58,2 / 100 | 0,66 |
 | Organogenesis Holdings Inc | 47.4 | Arzneimittel (Biotechnologie) | USA | 0.2 Mrd. USD | - | 9.20 | 0.42 | 0.67 | ▲ 10.73% | ▲ 15.59% | - | - | - | 6.58% | ▼ -3.07% | 9.92% | ▼ -1.63% | -4.34% | ▼ -1.90% | 5 / 9 | 6,17 | 10-fach | 71 / 100 | 7,9 / 100 | −1,46 |
 | Biogen Inc | 46.3 | Arzneimittel (Biotechnologie) | USA | 32.1 Mrd. USD | 38.42 | 11.90 | 3.23 | 1.70 | ▼ -6.11% | ▼ -20.22% | - | - | - | 13.18% | ▼ -1.51% | 19.14% | ▼ -1.52% | 20.90% | ▼ -0.44% | 5 / 9 | 5,62 | 7-fach | 23 / 100 | −3,1 / 100 | −2,49 |
 | Prestige Brand Holdings Inc | 43.5 | Arzneimittel (Pharmazeutisch) | USA | 2.2 Mrd. USD | 12.93 | 9.45 | 2.01 | 1.16 | ▲ 2.91% | ▲ 2.93% | - | - | - | 17.48% | ▲ 2.33% | 28.42% | ▲ 2.77% | 22.64% | ▲ 0.09% | 5 / 9 | 3,94 | 6-fach | 16 / 100 | −1,9 / 100 | −2,25 |
 | CytomX Therapeutics Inc | 41.7 | Arzneimittel (Biotechnologie) | USA | 0.7 Mrd. USD | - | - | 39.17 | 2.37 | ▲ 2.18% | ▼ -11.99% | - | - | - | -22.79% | ▲ 39.23% | -29.35% | ▲ 39.09% | -99.48% | ▲ 29.68% | 2 / 9 | −9,88 | unbegrenzt | 50 / 100 | 38,4 / 100 | −0,96 |
 | Beam Therapeutics Inc | 41.5 | Arzneimittel (Biotechnologie) | USA | 2.5 Mrd. USD | - | - | 15.88 | 2.32 | ▲ 466.27% | ▼ -16.29% | - | - | - | -57.24% | ▲ 114.93% | -274.57% | ▲ 86.62% | -257.65% | ▼ -59.65% | 5 / 9 | 6,77 | −3,2-fach | 8 / 100 | 17,9 / 100 | - |
 | Ironwood Pharmaceuticals Inc | 41.4 | Arzneimittel (Biotechnologie) | USA | 0.7 Mrd. USD | 5.19 | 3.63 | 1.73 | -4.17 | ▼ -5.33% | ▼ -25.72% | - | - | - | 8.11% | ▼ -28.16% | 40.10% | ▼ -6.65% | 42.89% | ▼ -7.79% | 7 / 9 | −11,90 | −8,3-fach | 75 / 100 | −26,0 / 100 | −5,72 |
 | Mirum Pharmaceuticals Inc | 40.9 | Arzneimittel (Biotechnologie) | USA | 6.4 Mrd. USD | - | - | 10.32 | -611.94 | ▲ 116.34% | ▼ -25.71% | - | - | - | -4.48% | ▲ 101.87% | -4.25% | ▲ 194.80% | 10.53% | ▲ 176.63% | 6 / 9 | 0,66 | −5,2-fach | 50 / 100 | −9,4 / 100 | −2,58 |
 | Immunome Inc | 39.4 | Arzneimittel (Biotechnologie) | USA | 2.8 Mrd. USD | - | - | 222.57 | 10.41 | - | - | - | - | - | -3059.99% | - | -3084.76% | - | -2890.13% | - | 4 / 9 | 13,99 | - | 1 / 100 | −3,1 / 100 | - |
 | ATAI Life Sciences BV | 39.3 | Arzneimittel (Biotechnologie) | USA | 2.7 Mrd. USD | - | - | 609.40 | 15.46 | ▼ -27.11% | ▲ 31.19% | 92.72% | - | - | -16142.02% | ▼ -1369.96% | -2439.74% | ▲ 2494.75% | -2533.04% | ▲ 1404.48% | 5 / 9 | −20,58 | −122,0-fach | 1 / 100 | −179,6 / 100 | −0,26 |
 | Crinetics Pharmaceuticals Inc | 39.0 | Arzneimittel (Biotechnologie) | USA | 9.0 Mrd. USD | - | - | 213.80 | 7.56 | ▲ 155.27% | ▲ 44.89% | - | - | - | -6046.22% | ▼ -1763.70% | -6714.77% | ▼ -2251.71% | -4985.50% | ▼ -1310.63% | 4 / 9 | 6,01 | - | 1 / 100 | −7,7 / 100 | 5,52 |
 | Assembly Biosciences Inc | 39.0 | Arzneimittel (Biotechnologie) | USA | 0.6 Mrd. USD | - | - | 8.11 | 1.99 | ▲ 35.27% | ▼ -42.53% | - | - | - | -8.47% | ▲ 207.57% | -16.76% | ▲ 209.26% | -56.93% | ▲ 141.45% | 5 / 9 | −1,18 | - | 28 / 100 | 13,6 / 100 | −1,52 |
 | UroGen Pharma Ltd | 38.8 | Arzneimittel (Biotechnologie) | USA | 2.1 Mrd. USD | - | - | 10.96 | -15.62 | ▲ 56.22% | ▲ 3.62% | - | - | - | -139.81% | ▲ 21.20% | -113.73% | ▲ 17.25% | -148.22% | ▲ 8.92% | 2 / 9 | −15,41 | −5,2-fach | 49 / 100 | 4,5 / 100 | −1,77 |
 | Zevra Therapeutics Inc. | 38.5 | Arzneimittel (Biotechnologie) | USA | 0.7 Mrd. USD | 12.24 | 21.90 | 5.24 | 3.28 | ▲ 51.62% | - | - | - | - | 78.17% | ▲ 3.27% | -3.98% | ▼ -1.15% | -2.29% | ▼ -18.67% | 6 / 9 | 2,88 | −1,9-fach | 32 / 100 | 29,8 / 100 | 1,47 |
 | Syndax Pharmaceuticals Inc | 38.4 | Arzneimittel (Biotechnologie) | USA | 1.6 Mrd. USD | - | - | 6.44 | 107.52 | ▲ 157.68% | ▲ 38.53% | - | - | - | -165.60% | ▲ 793.82% | -158.45% | ▲ 764.63% | -187.50% | ▲ 785.52% | 3 / 9 | −7,27 | −17,0-fach | 31 / 100 | 7,1 / 100 | 2,72 |
 | Inhibrx Biosciences, Inc. | 38.4 | Arzneimittel (Biotechnologie) | USA | 1.6 Mrd. USD | - | - | 1148.71 | 23.46 | ▼ -36.72% | ▲ 12.97% | - | - | - | -10773.46% | ▲ 83115.96% | -10386.54% | ▼ -17845.46% | -9986.54% | ▼ -11090.58% | 4 / 9 | −6,85 | 24-fach | −1 / 100 | −7,0 / 100 | 1,28 |
 | Atrium Therapeutics, Inc. Common Stock | 38.2 | Arzneimittel (Biotechnologie) | USA | 0.2 Mrd. USD | - | - | 4.93 | 0.83 | ▲ 22.36% | ▲ 11.76% | - | - | - | -411.88% | ▲ 56.86% | -412.58% | ▲ 16.87% | -228.67% | ▲ 33.82% | 4 / 9 | −11,82 | - | 7 / 100 | −12,8 / 100 | −3,71 |
 | Wave Life Sciences Ltd | 38.0 | Arzneimittel (Pharmazeutisch) | USA | 0.9 Mrd. USD | - | - | 13.84 | 1.99 | ▲ 16.31% | ▲ 6.39% | - | - | - | -478.33% | ▲ 398.53% | -504.09% | ▲ 396.93% | -440.50% | ▲ 295.50% | 3 / 9 | 1,34 | - | 5 / 100 | −2,6 / 100 | −2,25 |
 | Arvinas Inc | 37.9 | Arzneimittel (Pharmazeutisch) | USA | 0.6 Mrd. USD | 58.62 | - | 1.72 | 0.97 | ▲ 64.50% | ▼ -6.29% | - | - | - | -30.77% | ▲ 85.45% | -43.75% | ▲ 85.42% | -104.99% | ▼ -247.14% | 5 / 9 | −1,37 | - | 36 / 100 | 26,9 / 100 | −1,72 |
USA